Nikolina Lauc
Nikolina Lauc is the CEO and Co-Founder of GlycanAge, a pioneering longevity biotechnology company at the forefront of combatting chronic inflammation.
Under her leadership, GlycanAge is building the biomarker platforms, decision engines, and future therapeutics designed to measure and manage inflammaging. The company’s technology is anchored in over 30 years of scientific research and backed by more than €50 million in research funding. By assembling the world’s largest proprietary dataset of the human glycome, GlycanAge enables early detection of systemic inflammation and drives highly personalized preventive healthcare.
Today, Nikolina has scaled the platform to support over 350,000 glycan analyses across clinical and academic research, with healthcare providers in more than 60 countries actively integrating GlycanAge into their practices.


















